大麻二醇对治疗慢性疼痛的有效性:一个系统性审查
Sherin Yasser Mostafa Mohammed1, Kaizielyn Leis1, Ria Eunice Mercado1
1College of Pharmacy, Adamson University, Ermita, Manila, Philippines.
概括
大麻素 (CBD) 显示出缓解慢性疼痛的潜力,研究表明在许多患者中显著减少疼痛. 然而,由于研究的局限性,需要进行更强大的研究来确认其有效性.
科学领域:
- 药理学和疼痛管理
- 大麻素研究 研究 大麻素研究
背景情况:
- 大麻衍生化合物大麻二醇 (CBD) 已因其在治疗,焦虑和疼痛方面的治疗潜力而得到认可.
- 对于CBD治疗慢性疼痛的有效性,定义为持续不适超过3-6个月,仍然不完全理解.
研究的目的:
- 系统地审查和综合有关大麻素 (CBD) 对慢性疼痛管理有效性的现有证据.
主要方法:
- 根据PRISMA 2020指南进行了系统的文献审查.
- 搜索包括8个学术数据库和灰色文献,截至2022年8月30日,包括关于CBD治疗慢性疼痛的原始研究文章.
- 用GRADE方法评估偏差风险和证据确定性,通过叙事综合分析结果.
主要成果:
- 该综述包括15项涉及1516篇文章的研究.
- 大多数研究报告CBD单独或与四大麻素 (THC) 结合减少了42%至66%的疼痛.
- 三项研究没有发现显著的疼痛减轻,一项研究报告了混合的结果;疼痛测量方法各不相同,主要使用自我报告和秤.
结论:
- 大麻 (CBD) 可能为慢性疼痛治疗提供一个可行的选择.
- 由于研究数量有限,研究设计和结果衡量的异质性,目前的研究结果需要谨慎解释.
- 进一步的高质量研究和强大的方法是必不可少的,以确定CBD在慢性疼痛管理中的有效性.
相关概念视频
Analgesia and Pain Management
634
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
634
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
286
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
286
Chronic Pancreatitis II: Collaborative Care
95
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
95
Opioid Analgesics: Synthetic and Semisynthetic Opioids
310
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
310


